Therapy of Helicobacter pylori: current status and issues.
about
Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.New concepts of resistance in the treatment of Helicobacter pylori infectionsShort-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiomeTransfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole.Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.Antibacterial activities of almond skins on cagA-positive and-negative clinical isolates of Helicobacter pylori.High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori.In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori.Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment FailuresA soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth.Aspirin increases susceptibility of Helicobacter pylori to metronidazole by augmenting endocellular concentrations of antimicrobials.Intrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis.Effectiveness of Citrus Fruits on Helicobacter pyloriA novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori.Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR.Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes.
P2860
Q24530627-9CEC96F7-8428-4092-861D-72375D9B5F46Q24622513-29C0D73A-156D-4681-9EA3-9ADF6C9723FAQ33547430-A20DEF37-EF2A-41D0-8AD7-3C87AFC858E9Q33557158-6D30596B-E411-4A7E-B476-3B2A83382BEBQ34314718-56978101-8F2A-40B6-8CE8-14693AC5B917Q34713744-D77DDB02-EB1B-49AA-B540-4D415755C48AQ35102928-7CE26C82-20DE-4B8D-82C0-742C0EF1DE2AQ35721183-2CD84061-FC98-444F-9E4C-5BDA95FB8AA6Q35986780-029CEB71-7F80-4E1A-99A1-AE2FFE022216Q36368318-98A8E860-5453-4547-AEE5-39A2549C518DQ37122457-A59FC76A-B06D-4C70-9CE4-5E9E5416A0F2Q37155972-5B2E0F2E-B9D3-4F84-927C-E47A0EF6E35EQ37734375-0CCEB01E-D498-4C15-BE8E-9DE2E41EDA9BQ39537181-79A682E6-A280-4F1D-A59F-02DC3C0E3D2EQ39626198-E5373C44-DAB2-4A9F-8D85-336988A23DB5Q41003245-E8B13F20-35BC-4FB1-A906-80BBEAB40105
P2860
Therapy of Helicobacter pylori: current status and issues.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Therapy of Helicobacter pylori: current status and issues.
@ast
Therapy of Helicobacter pylori: current status and issues.
@en
type
label
Therapy of Helicobacter pylori: current status and issues.
@ast
Therapy of Helicobacter pylori: current status and issues.
@en
prefLabel
Therapy of Helicobacter pylori: current status and issues.
@ast
Therapy of Helicobacter pylori: current status and issues.
@en
P1433
P1476
Therapy of Helicobacter pylori: current status and issues.
@en
P407
P433
P577
2000-02-01T00:00:00Z